| Literature DB >> 19094239 |
Amanda D Goudie1, Karlene H Lynch, Kimberley D Seed, Paul Stothard, Savita Shrivastava, David S Wishart, Jonathan J Dennis.
Abstract
BACKGROUND: The Burkholderia cepacia complex (BCC) is a versatile group of Gram negative organisms that can be found throughout the environment in sources such as soil, water, and plants. While BCC bacteria can be involved in beneficial interactions with plants, they are also considered opportunistic pathogens, specifically in patients with cystic fibrosis and chronic granulomatous disease. These organisms also exhibit resistance to many antibiotics, making conventional treatment often unsuccessful. KS10 was isolated as a prophage of B. cenocepacia K56-2, a clinically relevant strain of the BCC. Our objective was to sequence the genome of this phage and also determine if this prophage encoded any virulence determinants.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19094239 PMCID: PMC2628397 DOI: 10.1186/1471-2164-9-615
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Electron micrographs showing morphology of KS10 particles in lysate stored at 4°C for approximately one week prior to imaging. Lysate was negatively stained with 2% phosphotungstic acid. Images were viewed at 110,000-fold magnification (A), and 140,000-fold magnification (B) using a Philips/FEI (Morgagni) Transmission Electron Microscope with CCD camera in the Biological Science Department's Microscopy Unit.
BCC strains/isolates testing positive for KS10 prophage.
| Host ( | Source | Integration Site |
| K56-2 | BCC experimental strain panel | Transcriptional regulator; GntR family with aminotransferase |
| J2315* | BCC experimental strain panel | Oxidoreductase on Chromosome 1 |
| C5424* | BCC experimental strain panel | ND |
| R1882 | Clinical Isolate | ND |
| R1883 | Clinical Isolate | ND |
| R1884 | Clinical Isolate | ND |
| S11528 | Clinical Isolate | ND |
| R1434 | Clinical Isolate | ND |
| R750 | Clinical Isolate | ND |
| R2314 | Clinical Isolate | ND |
| BCC experimental strain panel (modified, this study) | ND | |
| BCC experimental strain panel (modified, this study) | ND | |
| PC184 (lys3) | BCC experimental strain panel (modified, this study) | ND |
* – Also known to contain BcepMu
ND – Not determined
Figure 2Phage/Host DNA junction and putative transposase binding sites. (A) KS10 has integrated into an oxidoreductase gene of B. cenocepacia J2315. Within the J2315 genome, bases 1,728,819 through 1,766,551 are KS10 prophage sequence. Direction of transcription of surrounding genes is indicated with thick arrows, while the direction of transcription of KS10 genes is indicated with thin arrows. The diagram is not drawn to scale. (B) Uppercase letters indicate KS10 sequence while lowercase represent B. cenocepacia J2315 host DNA. Phage right end is on the left in this diagram due to its orientation in the J2315 genome, while the phage left end is on the right. (C) Four putative transposase binding sites at the terminal ends of KS10. The position and sequence of the four 15 nucleotide direct repeats that are predicted to be TnpA binding sites in KS10 are indicated. The L1 and L2 transposase binding sites, at the left end, are inverted relative to the R1 and R1 binding sites at the right end. All sequences are written 5'-3'. Consensus sequence is written in the direction of the R1 and R2 binding sites.
Phage KS10 putative genes and homologues
| 1 | 205–1437 | - | AGGCGcgtaaATG | 410 | virion morphogenesis | 400(28–418)/248(16–263) | 30%/33% | 160/137 | 63.26 | Pseudomonas bacteriophage B3 gp33/BcepMu gp30 |
| 2 | 1438–1698 | - | AAAGGAGccaacaATG | 86 | hyp. protein | - | - | - | 61.69 | no sig. match |
| 3 | 1743–3278 | - | GGAAG//36 bp//cgtttATG | 511 | portal | 354(35–374) | 32% | 182 | 62.57 | BcepMu gp29 |
| 4 | 3268–4884 | - | AAGAGGcctgatccacgATG | 538 | terminase large subunit** | 520(4–521) | 55% | 569 | 58.94 | D3112 p26 |
| 5 | 4891–5388 | - | AAGGGttgacgcATG | 165 | terminase small subunit** | 164(1–164) | 37% | 161 | 59.24 | D3112 p24 |
| 6 | 5392–5682 | - | AGGGTATccgcgATG | 96 | hyp. protein | - | - | - | 59.45 | no sig. match |
| 7 | 5679–5903 | - | GGATAacgATG | 74 | dksA/traR C4-type zinc finger | 74(1–72) | 45% | 44.3 | 60.89 | Enterobateria phage WPhi gp82 |
| 8 | 5893–6186 | - | GAGGAtgcccgtcATG | 102 | hyp. protein | - | - | - | 65.99 | no sig. match |
| 9 | 6466–7137 | - | GTGGGcctcgcagcATG | 223 | endolysin | 186(20–203) | 54% | 188 | 65.03 | BcepMu gp22 |
| 10 | 7134–7535 | - | GGGTGccgccgtcgcgaATG | 133 | holin | 119(1–111)/116(8–113) | 36%/39% | 72.4/63.5 | 58.96 | |
| 11 | 7650–8258 | - | GGGAAGcgcgaaATG | 202 | hyp. protein | 177(53–211) | 26% | 45.4 | 53.53 | |
| 12 | 8251–8784 | - | GGGAATAtgtaaagcATG | 177 | hyp. protein | - | - | - | 54.87 | no sig. match |
| 13 | 8839–9309 | - | AAGAGGccgaccATG | 156 | hyp. protein/phage repressor | 131(1–125)/137(2–127) | 39%/36% | 85.1/72.4 | 56.69 | |
| 14 | 9391–9582 | + | GGAGcaaatATG | 63 | DNA binding protein/conserved hyp. protein | 62(5–65)/59(1–57) | 33%/52% | 38.1/65.1 | 58.85 | BcepMu gp16/ |
| 15 | 9579–10631 | + | GGGGAGGtggATG | 350 | conserved hyp. protein | 141(49–186)/127(77–203) | 28%/28% | 38.1/44.7 | 64.71 | BcepMu gp10/ |
| 16 | 10671–12296 | + | AGGTGcgatATG | 541 | transposase | 539(24–559) | 36% | 336 | 65.19 | |
| 17 | 12306–13298 | + | GAATAAGGAGtgaccATG | 330 | transposition protein | 309(7–311) | 42% | 222 | 64.15 | |
| 18 | 13306–13494 | + | GTGAGGccatcATG | 62 | hyp. protein | - | - | - | 66.14 | no sig. match |
| 19 | 13491–13796 | + | GAGGTGAcggcATG | 101 | hyp. protein | - | - | - | 69.28 | no sig. match |
| 20 | 13859–14371 | + | TGGccgacgacagcATG | 170 | hyp. protein | 172(55–187) | 60% | 180 | 67.25 | |
| 21 | 14368–14994 | + | AAGGAAcccatcATG | 208 | conserved protein | 200(9–210)/199(6–204) | 72%/55% | 210/205 | 63 | |
| 22 | 15005–15397 | + | GAGGGGctggccATG | 130 | hyp. protein | - | - | - | 66.16 | no sig. match |
| 23 | 15460–15732 | + | AGGAGAAAcaccctcATG | 90 | DNA binding protein Hu-beta | 90(1–90) | 57% | 108 | 64.47 | |
| 24 | 15809–16642 | + | GAGGAAccccaaaATG | 277 | hyp. protein | 117(51167)/58(344–401) | 53%/67% | 114 | 62.83 | |
| 25 | 16806–17126 | + | GGGGAGTGAcactgtgATG | 106 | hyp. protein | 111(9–119) | 37% | 55.1 | 64.49 | |
| 26 | 17128–17568 | + | GGAGGcccgctgacATG | 146 | modulation of host genes? | 129(9–135) | 30% | 58.5 | 64.17 | |
| 27 | 17565–17963 | + | GAAACGAccgcATG | 132 | middle operon regulator (Mor)**** | 106(14–118) | 31% | 52.8 | 64.91 | |
| 28 | 18120–19322 | + | AGAGAAccatTTG | 400 | protease | 330(10–322) | 33% | 147 | 65.59 | BcepMu gp32 |
| 29 | 18876–19322 | + | AGGAagccATG | 148 | scaffold | - | - | - | 67.11 | BcepMu gp33 |
| 30 | 19368–19724 | + | AGAGGATtcacATG | 118 | conserved hyp. protein | 77(41–117)/80(32–109) | 54%/42% | 72.4/44.3 | 71.71 | Bacteriophage B3 gp37/BcepMu gp35 |
| 31 | 19775–20722 | + | GGAGctatccATG | 315 | major head subunit | 311(4–307) | 47% | 243 | 64.87 | Bacteriophage B3 gp34 |
| 32 | 20797–21186 | + | AAGAGAGatcATG | 129 | hyp. protein | - | - | - | 66.92 | no sig. match |
| 33 | 21183–21686 | + | GAAGGGccgcaaATG | 167 | hyp. protein | - | - | - | 65.48 | no sig. match |
| 34 | 21683–22114 | + | GGATAGGTAcgggaaATG | 143 | virion morph. | 161(8–156) 121(7–124) | 31%/36% | 161/52.4 | 60.19 | |
| 35 | 22114–22716 | + | GGTGAGGATGAtgtgATG | 200 | phage-related conserved hyp. protein | 165(1–164) | 24% | 41.2 | 61.36 | |
| 36 | 22700–22978 | + | ACGGG//25 bp//gatATG | 92 | hyp. protein | - | - | - | 64.52 | no sig. match |
| 37 | 23022–24500 | + | AAGGGAcattcgacATG | 492 | tail sheath protein | 472(12–481) | 34% | 188 | 63.15 | Prophage MuSo2 ( |
| 38 | 24546–24917 | + | AAGGGAGTGaaacATG | 123 | hyp. protein | - | - | - | 62.9 | no sig. match |
| 39 | 25000–25554 | + | TGAGATTcccaccATG | 184 | tail assembly chaperone | - | - | - | 62.88 | FluMu gp41** |
| 40 | 25603–28038 | + | GAGGAAGAgacgATG | 811 | tail tape measure (TP109 fam.) | 484(3–458) | 38% | 265 | 64.2 | |
| 41 | 28038–29408 | + | GGAGGAAcgaactgATG | 456 | DNA circulation protein | 455(3–412) | 27% | 150 | 65.43 | |
| 42 | 29414–30571 | + | TGAcccctATG | 385 | tail protein | 352(96–337) | 33% | 153 | 63.04 | |
| 43 | 30571–31092 | + | GGAGcaaactgATG | 173 | baseplate assembly | 60(36–188) | 30% | 63.5 | 61.88 | |
| 44 | 31177–31758 | + | AGGccatcATG | 193 | tail protein | 99(25–112) | 47% | 70.9 | 64.6 | MuV (gp46) |
| 45 | 31755–32876 | + | GGAAAAcatcATG | 476 | tail protein | 306(24–325) | 36% | 144 | 65.86 | |
| 46 | 32879–33478 | + | AGGAGTgaccGTG | 173 | tail protein | 197(5–192) | 26% | 57 | 65.17 | |
| 47 | 33478–34455 | + | GGAcatcgactgATG | 325 | tail fiber protein | 229(310–534) | 42% | 140 | 62.47 | |
| 48 | 34463–36691 | + | TGAGGcacgcATG | 742 | ABC-type phosphate transport sys. | 459(40–493) | 46% | 364 | 60 | |
| 49 | 36711–37475 | + | GAGGTAcaaATG | 254 | hyp. protein | 270(1–248) | 28% | 81.3 | 59.48 | Klebsiella pneumoniae 342 KPK_4114 |
Abbreviations: GP, gene product; Str., strand; RBS, ribosome-binding site; AA, amino acid; hyp, hypothetical; sig, significant; subsp, subspecies;
*Putative RBS binding sites for gp1, gp4, and gp37 were identified using RBS finder.
**Function predicted using PSI-BLAST
***All R. solanacearum UW551 references refer to unfinished DNA segment NZ_AAKL01000024.1
****Function predicted using PHYRE database
Figure 3Genome maps of KS10 and related phages BcepMu and Mu (derived from NC_005882 and NC_000929, respectively). Each box represents a predicted gene drawn to scale using GenVision program (DNASTAR) and arrows indicate direction of transcription. Homologues and known phage proteins are indicated (Table 1). Different colors represent different modules. Dark grey boxes indicate genes with no known phage homologues and are annotated as hypothetical proteins.
Figure 4Mu relationships identified using Artemis Comparison Tool program. Translated BLAST (tblastx) was used to align translated genomic sequences of phages KS10, BcepMu, and Mu. An E-value cutoff of 10 and a score cutoff of 40 were used in this comparison. Nucleotide basepairs are indicated between grey lines for each phage genome. The blue and red lines represent the reverse and forward matches, respectively, and color intensity is proportional to the sequence homology.